Lucira Health Inc
NASDAQ:LHDX
Lucira Health Inc
Accounts Payable
Lucira Health Inc
Accounts Payable Peer Comparison
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
L
|
Lucira Health Inc
NASDAQ:LHDX
|
Accounts Payable
$19.4m
|
CAGR 3-Years
175%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Becton Dickinson and Co
NYSE:BDX
|
Accounts Payable
$5.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
11%
|
|
Boston Scientific Corp
NYSE:BSX
|
Accounts Payable
$921m
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
|
Stryker Corp
NYSE:SYK
|
Accounts Payable
$1.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
15%
|
CAGR 10-Years
14%
|
|
Abbott Laboratories
NYSE:ABT
|
Accounts Payable
$4.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accounts Payable
$194.4m
|
CAGR 3-Years
24%
|
CAGR 5-Years
8%
|
CAGR 10-Years
13%
|
See Also
What is Lucira Health Inc's Accounts Payable?
Accounts Payable
19.4m
USD
Based on the financial report for Dec 31, 2021, Lucira Health Inc's Accounts Payable amounts to 19.4m USD.
What is Lucira Health Inc's Accounts Payable growth rate?
Accounts Payable CAGR 3Y
175%
Over the last year, the Accounts Payable growth was 387%. The average annual Accounts Payable growth rates for Lucira Health Inc have been 175% over the past three years .